MRKR
Marker Therapeutics, Inc.
Price Chart
Latest Quote
$1.36
-0.01 (-0.72%)
Current Price
| Previous Close | $1.37 |
| Open | $1.37 |
| Day High | $1.39 |
| Day Low | $1.35 |
| Volume | 13,365 |
Stock Information
| Shares Outstanding | 16.67M |
| Cash Equivalents | $14.92M |
| Revenue | $3.55M |
| Net Income | $-10.90M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $22.68M |
| EPS (TTM) | $-0.55 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $7.93M |
| Sales | $3.55M |
| Income | $-10.90M |
| Book/sh | $0.83 |
| Cash/sh | $0.89 |
| Employees | 5 |
Financial Ratios
| Quick Ratio | 4.48 |
| Current Ratio | 4.79 |
Returns & Margins
| ROA | -43.59% |
| ROE | -77.04% |
| Gross Margin | -224.43% |
| Operating Margin | -338.49% |
Ownership
| Insider Ownership | 5.49% |
| Institutional Ownership | 23.40% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -8.00 |
| P/S | 6.39 |
| P/B | 1.64 |
Analyst Data
| Recommendation | none |
| Target Price | $7.87 |
Technical Indicators
| SMA20 | $1.42 |
| SMA50 | $1.45 |
| SMA200 | $1.35 |
| RSI | 37.15 |
| ATR | 0.0540 |
| Shares Float | 13.81M |
| Short Float | 1.51% |
| Short Ratio | 3.21 |
| Volatility | 1.45 |
| Rel Volume | 0.23 |
Performance History
| Week | +0.75% |
| Month | -2.85% |
| Quarter | +7.94% |
| 6 Months | +6.26% |
| YTD | -11.68% |
| Year | -4.22% |
| 3 Years | -56.68% |
| 5 Years | -95.83% |
| 10 Years | -97.78% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $1.36 | 13,365 |
| 2026-06-23 | $1.37 | 19,500 |
| 2026-06-22 | $1.37 | 43,200 |
| 2026-06-18 | $1.33 | 46,600 |
| 2026-06-17 | $1.35 | 33,500 |
| 2026-06-16 | $1.35 | 72,100 |
| 2026-06-15 | $1.35 | 51,300 |
| 2026-06-12 | $1.38 | 28,500 |
| 2026-06-11 | $1.37 | 156,300 |
| 2026-06-10 | $1.43 | 27,500 |
| 2026-06-09 | $1.41 | 27,300 |
| 2026-06-08 | $1.46 | 88,800 |
| 2026-06-05 | $1.42 | 52,900 |
| 2026-06-04 | $1.47 | 65,800 |
| 2026-06-03 | $1.45 | 26,300 |
| 2026-06-02 | $1.42 | 92,000 |
| 2026-06-01 | $1.52 | 78,700 |
| 2026-05-29 | $1.57 | 92,000 |
| 2026-05-28 | $1.51 | 107,100 |
| 2026-05-27 | $1.45 | 40,200 |
| 2026-05-26 | $1.45 | 64,100 |
About Marker Therapeutics, Inc.
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. The company's multi antigen recognizing (MAR)-T cell therapy technology is based on the selective expansion of non-engineered tumor-specific T cells that recognize tumor-associated antigens and kill tumor cells expressing those targets. It develops MT-601, which is in Phase 1 trials for the treatment of lymphoma and pancreatic cancer; and MT-401-OTS, which is in a Phase 1 trial for the treatment of acute myeloid leukemia and myelodysplastic syndromes. The company was formerly known as TapImmune, Inc. and changed its name to Marker Therapeutics, Inc. in October 2018. Marker Therapeutics, Inc. was founded in 1999 and is headquartered in Houston, Texas.
đ° Latest News
Exploring 3 High Growth Tech Stocks in US Market
Simply Wall St. âĸ 2026-06-15T11:39:04Z
Exploring High Growth Tech Stocks In The US Market
Simply Wall St. âĸ 2026-06-11T11:38:33Z
Exploring 3 High Growth Tech Stocks in the US Market
Simply Wall St. âĸ 2026-06-09T11:38:22Z
US High Growth Tech Stocks with Promising Potential
Simply Wall St. âĸ 2026-06-05T11:38:28Z
High Growth Tech Stocks To Watch In US June 2026
Simply Wall St. âĸ 2026-06-03T11:38:21Z
3 High Growth Tech Stocks To Watch In The US Market
Simply Wall St. âĸ 2026-06-02T11:38:24Z
Top 3 High Growth Tech Stocks in the US Market
Simply Wall St. âĸ 2026-06-01T17:38:46Z
High Growth Tech Stocks in US for May 2026
Simply Wall St. âĸ 2026-05-29T17:38:31Z
US High Growth Tech Stocks To Watch
Simply Wall St. âĸ 2026-05-28T17:38:45Z
Exploring High Growth Tech Stocks In The US Market May 2026
Simply Wall St. âĸ 2026-05-28T11:38:13Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $3,311,133 | $0 |
| Operating Revenue | $0 | $0 | $3,311,133 | $0 |
| Expenses | ||||
| Total Expenses | $12,437,291 | $11,118,372 | $14,581,378 | $19,791,004 |
| Other Income Expense | $-335,691 | - | - | $-232,974 |
| Other Non Operating Income Expenses | $117,444 | - | - | $-232,974 |
| Net Non Operating Interest Income Expense | $594,206 | $437,010 | $539,158 | $248,063 |
| Operating Expense | $12,437,291 | $11,118,372 | $14,581,378 | $19,791,004 |
| Other Operating Expenses | $-3,546,669 | $-6,591,080 | $-3,311,133 | $-3,513,544 |
| General And Administrative Expense | $4,184,806 | $4,241,607 | $7,475,722 | $11,336,120 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-12,163,620 | $-10,731,315 | $-14,045,895 | $-19,775,915 |
| Net Interest Income | $594,206 | $437,010 | $539,158 | $248,063 |
| Interest Income | $594,206 | $437,010 | $539,158 | $248,063 |
| Normalized Income | $-11,710,485 | $-10,731,315 | $-14,045,895 | $-19,775,915 |
| Net Income From Continuing And Discontinued Operation | $-12,163,620 | $-10,731,315 | $-8,236,814 | $-29,930,694 |
| Total Operating Income As Reported | $-12,890,426 | $-11,118,372 | $-14,581,378 | $-19,791,004 |
| Net Income Common Stockholders | $-12,163,620 | $-10,731,315 | $-8,236,814 | $-29,930,694 |
| Net Income | $-12,163,620 | $-10,731,315 | $-8,236,814 | $-29,930,694 |
| Net Income Including Noncontrolling Interests | $-12,163,620 | $-10,731,315 | $-8,236,814 | $-29,930,694 |
| Net Income Continuous Operations | $-12,163,620 | $-10,731,315 | $-14,045,895 | $-19,775,915 |
| Pretax Income | $-12,178,776 | $-10,681,362 | $-10,731,087 | $-19,775,915 |
| Special Income Charges | $-453,135 | $0 | - | - |
| Interest Income Non Operating | $594,206 | $437,010 | $539,158 | $248,063 |
| Operating Income | $-12,437,291 | $-11,118,372 | $-11,270,245 | $-19,791,004 |
| Net Income Discontinuous Operations | - | $0 | $5,809,081 | $-10,154,779 |
| Per Share | ||||
| Diluted EPS | $-0.79 | $-1.19 | $-0.94 | $-3.58 |
| Basic EPS | $-0.79 | $-1.19 | $-0.94 | $-3.58 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-11,984,156 | $-11,118,372 | $-11,270,245 | $-19,791,004 |
| Total Unusual Items | $-453,135 | $0 | - | - |
| Total Unusual Items Excluding Goodwill | $-453,135 | $0 | - | - |
| EBITDA (Bullshit earnings) | $-12,437,291 | $-11,118,372 | $-11,270,245 | $-19,791,004 |
| EBIT | $-12,437,291 | $-11,118,372 | $-11,270,245 | $-19,791,004 |
| Diluted Average Shares | $15,310,308 | $8,980,207 | $8,809,382 | $8,351,003 |
| Basic Average Shares | $15,310,308 | $8,980,207 | $8,809,382 | $8,351,003 |
| Diluted NI Availto Com Stockholders | $-12,163,620 | $-10,731,315 | $-8,236,814 | $-29,930,694 |
| Tax Provision | $-15,156 | $49,953 | $3,675 | $0 |
| Other Special Charges | $453,135 | - | - | - |
| Research And Development | $11,799,154 | $13,467,845 | $10,416,789 | $11,968,428 |
| Selling General And Administration | $4,184,806 | $4,241,607 | $7,475,722 | $11,336,120 |
| Other Gand A | $4,184,806 | $4,241,607 | $7,475,722 | $11,336,120 |
| Reconciled Depreciation | - | - | - | $3,680,449 |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $16,796,814 | $18,558,406 | $14,052,543 | $19,601,037 |
| Total Assets | $19,070,997 | $22,022,860 | $17,127,391 | $34,422,184 |
| Total Non Current Assets | $0 | $0 | $0 | $17,802,929 |
| Current Assets | $19,070,997 | $22,022,860 | $17,127,391 | $16,619,255 |
| Restricted Cash | $974,799 | $0 | - | $0 |
| Prepaid Assets | $658,750 | $483,717 | $988,126 | $1,849,239 |
| Receivables | $1,369,400 | $2,346,703 | $1,027,815 | $2,402,004 |
| Other Receivables | $1,369,400 | $2,346,703 | $1,027,815 | $2,402,004 |
| Cash Cash Equivalents And Short Term Investments | $16,068,048 | $19,192,440 | $15,111,450 | $11,782,172 |
| Cash And Cash Equivalents | $16,068,048 | $19,192,440 | $15,111,450 | $11,782,172 |
| Assets Held For Sale Current | - | - | $0 | $585,840 |
| Other Non Current Assets | - | - | - | $17,802,929 |
| Debt | ||||
| Total Debt | - | - | - | $7,616,536 |
| Long Term Debt And Capital Lease Obligation | - | - | - | $7,039,338 |
| Current Debt And Capital Lease Obligation | - | - | - | $577,198 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,274,183 | $3,464,454 | $3,074,848 | $14,821,147 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $7,039,338 |
| Current Liabilities | $2,274,183 | $3,464,454 | $3,074,848 | $7,781,809 |
| Current Deferred Liabilities | $974,799 | $0 | - | $2,500,000 |
| Payables And Accrued Expenses | $1,212,301 | $3,378,104 | $3,017,655 | $1,771,000 |
| Payables | $848,365 | $2,881,486 | $2,509,655 | $1,101,000 |
| Total Tax Payable | $54,638 | $104,591 | $219,000 | $0 |
| Accounts Payable | $793,727 | $1,066,395 | $961,000 | $1,101,000 |
| Other Current Liabilities | - | $954 | $193 | $5,260,809 |
| Liabilities Heldfor Sale Non Current | - | - | $0 | $7,039,338 |
| Equity | ||||
| Common Stock Equity | $16,796,814 | $18,558,406 | $14,052,543 | $19,601,037 |
| Total Equity Gross Minority Interest | $16,796,814 | $18,558,406 | $14,052,543 | $19,601,037 |
| Stockholders Equity | $16,796,814 | $18,558,406 | $14,052,543 | $19,601,037 |
| Retained Earnings | $-459,180,798 | $-447,017,178 | $-436,285,863 | $-428,049,049 |
| Other | ||||
| Ordinary Shares Number | $16,673,127 | $10,709,005 | $8,900,000 | $8,400,000 |
| Share Issued | $16,673,127 | $10,709,005 | $8,900,000 | $8,400,000 |
| Tangible Book Value | $16,796,814 | $18,558,406 | $14,052,543 | $19,601,037 |
| Invested Capital | $16,796,814 | $18,558,406 | $14,052,543 | $19,601,037 |
| Working Capital | $16,796,814 | $18,558,406 | $14,052,543 | $8,837,446 |
| Total Capitalization | $16,796,814 | $18,558,406 | $14,052,543 | $19,601,037 |
| Additional Paid In Capital | $475,960,940 | $465,564,876 | $450,329,515 | $447,641,680 |
| Capital Stock | $16,672 | $10,708 | $8,891 | $8,406 |
| Common Stock | $16,672 | $10,708 | $8,891 | $8,406 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Current Deferred Revenue | $974,799 | $0 | - | $2,500,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $87,083 | $86,350 | $57,000 | $750,000 |
| Current Accrued Expenses | $363,936 | $496,618 | $508,000 | $670,000 |
| Dueto Related Parties Current | $0 | $1,710,500 | $1,329,655 | $0 |
| Capital Lease Obligations | - | - | - | $7,616,536 |
| Long Term Capital Lease Obligation | - | - | - | $7,039,338 |
| Current Capital Lease Obligation | - | - | - | $577,198 |
| Net PPE | - | - | - | $17,802,786 |
| Accumulated Depreciation | - | - | - | $-5,274,000 |
| Gross PPE | - | - | - | $23,076,786 |
| Leases | - | - | - | $3,950,000 |
| Construction In Progress | - | - | - | $0 |
| Other Properties | - | - | - | $17,303,786 |
| Machinery Furniture Equipment | - | - | - | $1,823,000 |
| Properties | - | - | - | $0 |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-12,014,081 | $-10,910,324 | $-16,439,961 | $-26,972,153 |
| Operating Activities | ||||
| Operating Cash Flow | $-12,014,081 | $-10,910,324 | $-16,439,961 | $-26,972,153 |
| Cash Flow From Continuing Operating Activities | $-12,014,081 | $-10,910,324 | $-10,341,062 | $-21,513,478 |
| Cash From Discontinued Operating Activities | - | $0 | $-6,098,899 | $-5,458,675 |
| Operating Gains Losses | - | - | - | $25,995 |
| Investing Activities | ||||
| Investing Cash Flow | - | $0 | $18,664,122 | $-4,945,136 |
| Cash From Discontinued Investing Activities | - | $0 | $18,664,122 | $-4,945,136 |
| Capital Expenditure | - | - | - | $-4,945,136 |
| Cash Flow From Continuing Investing Activities | - | - | - | $-4,945,136 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $9,863,883 | $14,929,155 | $1,014,640 | $202,130 |
| Financing Cash Flow | $9,864,488 | $14,991,314 | $1,105,117 | $202,130 |
| Cash Flow From Continuing Financing Activities | $9,864,488 | $14,991,314 | $1,105,117 | $202,130 |
| Net Common Stock Issuance | $9,863,883 | $14,929,155 | $1,014,640 | $202,130 |
| Common Stock Issuance | $9,863,883 | $14,929,155 | $1,014,640 | $202,130 |
| Other | ||||
| End Cash Position | $17,042,847 | $19,192,440 | $15,111,450 | $11,782,172 |
| Beginning Cash Position | $19,192,440 | $15,111,450 | $11,782,172 | $43,497,331 |
| Changes In Cash | $-2,149,593 | $4,080,990 | $3,329,278 | $-31,715,159 |
| Proceeds From Stock Option Exercised | $605 | $62,159 | $90,477 | $0 |
| Change In Working Capital | $-388,001 | $-424,873 | $2,846,564 | $-4,763,516 |
| Change In Other Working Capital | $974,799 | - | - | $-1,146,186 |
| Change In Payables And Accrued Expense | $-2,165,070 | $389,606 | $611,262 | $-1,319,710 |
| Change In Payable | $-2,165,070 | $389,606 | $611,262 | - |
| Change In Account Payable | $-454,570 | $8,761 | $-718,393 | - |
| Change In Prepaid Assets | $-175,033 | $504,409 | $861,113 | $104,147 |
| Change In Receivables | $977,303 | $-1,318,888 | $1,374,189 | $-2,401,767 |
| Stock Based Compensation | $537,540 | $245,864 | $858,269 | $3,304,634 |
| Net Income From Continuing Operations | $-12,163,620 | $-10,731,315 | $-14,045,895 | $-19,775,915 |
| Net PPE Purchase And Sale | - | - | - | $-4,945,136 |
| Purchase Of PPE | - | - | - | $-4,945,136 |
| Change In Other Current Liabilities | - | - | - | $-513,891 |
| Other Non Cash Items | - | - | - | $-278,681 |
| Depreciation Amortization Depletion | - | - | - | $3,680,449 |
| Depreciation And Amortization | - | - | - | $3,680,449 |
| Depreciation | - | - | - | $3,680,449 |
| Gain Loss On Sale Of PPE | - | - | - | $25,995 |
Fetched: 2026-06-20